Prevalence of Latent Tuberculosis (TB) Infection Diagnosed by Interferon-gamma Release Assay and Tuberculin Skin Tests in Patients With Old Healed TB
This study has been completed.
Sponsor:
Seoul National University Hospital
Information provided by:
Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT01099098
First received: April 4, 2010
Last updated: May 11, 2011
Last verified: May 2011
| Tracking Information | |
|---|---|
| First Received Date ICMJE | April 4, 2010 |
| Last Updated Date | May 11, 2011 |
| Start Date ICMJE | January 2010 |
| Primary Completion Date | January 2011 (final data collection date for primary outcome measure) |
| Current Primary Outcome Measures ICMJE |
Prevalence of latent TB infection [ Time Frame: At enrollment ] [ Designated as safety issue: No ] |
| Original Primary Outcome Measures ICMJE | Not Provided |
| Change History | Complete list of historical versions of study NCT01099098 on ClinicalTrials.gov Archive Site |
| Current Secondary Outcome Measures ICMJE | Not Provided |
| Original Secondary Outcome Measures ICMJE | Not Provided |
| Current Other Outcome Measures ICMJE | Not Provided |
| Original Other Outcome Measures ICMJE | Not Provided |
| Descriptive Information | |
| Brief Title ICMJE | Prevalence of Latent Tuberculosis (TB) Infection Diagnosed by Interferon-gamma Release Assay and Tuberculin Skin Tests in Patients With Old Healed TB |
| Official Title ICMJE | Not Provided |
| Brief Summary | We easily regard nodules and fibrosis in upper lobes of lung as TB sequelae. The aim of this study is to confirm the prevalence of latent TB infection diagnosed by interferon-gamma release assay and tuberculin skin tests in patients with old healed TB. |
| Detailed Description | Not Provided |
| Study Type ICMJE | Observational |
| Study Design ICMJE | Observational Model: Case Control Time Perspective: Prospective |
| Target Follow-Up Duration | Not Provided |
| Biospecimen | Not Provided |
| Sampling Method | Non-Probability Sample |
| Study Population | Patients with TB sequelae in their CXR |
| Condition ICMJE | Tuberculosis |
| Intervention ICMJE | Not Provided |
| Study Group/Cohort (s) |
|
| Publications * | Not Provided |
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|
| Recruitment Information | |
| Recruitment Status ICMJE | Completed |
| Estimated Enrollment ICMJE | 480 |
| Completion Date | March 2011 |
| Primary Completion Date | January 2011 (final data collection date for primary outcome measure) |
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
| Gender | Both |
| Ages | 20 Years to 80 Years |
| Accepts Healthy Volunteers | Yes |
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects |
| Location Countries ICMJE | Korea, Republic of |
| Administrative Information | |
| NCT Number ICMJE | NCT01099098 |
| Other Study ID Numbers ICMJE | H-0909-054-295 |
| Has Data Monitoring Committee | No |
| Responsible Party | Jae-Joon Yim / Associate Professor, Seoul National University Hospital |
| Study Sponsor ICMJE | Seoul National University Hospital |
| Collaborators ICMJE | Not Provided |
| Investigators ICMJE | Not Provided |
| Information Provided By | Seoul National University Hospital |
| Verification Date | May 2011 |
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|